Stockreport

AVROBIO Announces Proposed Public Offering of Common Stock

AVROBIO, Inc.  (AVRO) 
Last avrobio, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.avrobio.com/investor-relations
PDF CAMBRIDGE, Mass--(BUSINESS WIRE)--AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced that it intends to off [Read more]